JSM 2013 Home
Online Program Home
My Program

Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.

Activity Details

686 Thu, 8/8/2013, 10:30 AM - 12:20 PM CC-511c
Statistical Methods for Adaptive Designs — Contributed Papers
Biopharmaceutical Section , Biometrics Section
Chair(s): Olga Marchenko, Quintiles
10:35 AM Adaptive Designs for Dose-Ranging Studies Based on Group-Sequential Methods Yevgen Tymofyeyev, Janssen RD of J&J ; Jose Carlos Pinheiro, Janssen R&D
10:50 AM Stage-Wise Optimal Adaptive Dose Study Design Gang Jia, Merck & Co.
11:05 AM Futility Analysis in a Phase II Clinical Trial Bo Jin, Pfizer Inc.
11:20 AM Strategies Considered in Designing an FTIH Trial Yu Lou, GlaxoSmithKline ; Jianjun Gan, GlaxoSmithKline
11:35 AM Seamless Phase IIa/IIb and Enhanced Dose Finding Adaptive Design Jiacheng Yuan, Novartis ; Herbert Pang, DU School of Medicine ; Tiejun Tong, Hong Kong Baptist University
11:50 AM Optimal Timing for Interim Analysis in Phase 2 Drug Development: A Real Options Approach Ouhong Wang, Amgen
12:05 PM Multi-Stage Clinical Trial Design with Multidimensional Mixed Endpoints Peng Huang, Johns Hopkins University - Oncology Biostatistics ; Ming Tan, Georgetown University Medical Center

2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.